Free Access
Issue
Réanimation
Volume 25, Mai 2016
Infectieux
Page(s) S69 - S82
Section Mise Au Point / Update
DOI https://doi.org/10.1007/s13546-016-1197-4
Published online 13 April 2016
  • Dumas M (1997) Ce qu'on devrait savoir sur les parasitoses du système nerveux. La lettre du neurologue Hors-série 65–70 [Google Scholar]
  • Jauréguiberry S, Caumes E (2007) Parasitoses du système nerveux central. In: Traité de médecine Akos. Elsevier Masson, pp 4–1360 [Google Scholar]
  • Jauréguiberry S, Ansart S, Perez L, et al (2007) Acute neuroschistosomiasis: two cases associated with cerebral vasculitis. Am J Trop Med Hyg 76:964–6 [PubMed] [Google Scholar]
  • Planche T, Krishna S (2005) The relevance of malaria pathophysiology to strategies of clinical management. Curr Opin Infect Dis 18:369–75 [CrossRef] [PubMed] [Google Scholar]
  • Pain A, Ferguson DJ, Kai O, et al (2001) Platelet-mediated clumping of Plasmodium falciparum-infected erythrocytes is a common adhesive phenotype and is associated with severe malaria. Proc Natl Acad Sci USA 98:1805–10 [CrossRef] [Google Scholar]
  • Doumbo OK, Thera MA, Koné AK, et al (2009) High levels of Plasmodium falciparum rosetting in all clinical forms of severe malaria in African children. Am J Trop Med Hyg 81:987–93 [CrossRef] [PubMed] [Google Scholar]
  • Carlson J, Helmby H, Hill AV, et al (1990) Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet 336:1457–60 [CrossRef] [PubMed] [Google Scholar]
  • White NJ, Pukrittayakamee S, Hien TT, et al (2014) Malaria. Lancet 383:723–35 [CrossRef] [PubMed] [Google Scholar]
  • Ponsford MJ, Medana IM, Prapansilp P, et al (2012) Sequestration and microvascular congestion are associated with coma in human cerebral malaria. J Infect Dis 205:663–71 [CrossRef] [PubMed] [Google Scholar]
  • Miller LH, Ackerman HC, Su XZ, Wellems TE (2013) Malaria biology and disease pathogenesis: insights for new treatments. Nat Med 19:156–67 [CrossRef] [PubMed] [Google Scholar]
  • Cabantous S, Poudiougou B, Traore A, et al (2005) Evidence that interferon-gamma plays a protective role during cerebral malaria. J Infect Dis 192:854–60 [CrossRef] [PubMed] [Google Scholar]
  • de Jesus AR, Silva A, Santana LB, et al (2002) Clinical and immunologic evaluation of 31 patients with acute Schistosomiasis mansoni. J Infect Dis 185:98–105 [CrossRef] [PubMed] [Google Scholar]
  • Bruneel F, Tubach F, Corne P, et al (2010) Severe imported falciparum malaria: a cohort study in 400 critically ill adults. PLoS One 5:e13236 [Google Scholar]
  • Kochar DK, Shubhakaran, Kumawat BL, et al (2002) Cerebral malaria in Indian adults: a prospective study of 441 patients from Bikaner, North-West India. J Assoc Physicians India 50:234–41 [PubMed] [Google Scholar]
  • Roze E, Thiebaut MM, Mazevet D, et al (2001) Neurologic sequelae after severe falciparum malaria in adult travelers. Eur Neurol 46:192–7 [CrossRef] [PubMed] [Google Scholar]
  • Looareesuwan S, Wilairatana P, Krishna S, et al (1995) Magnetic resonance imaging of the brain in patients with cerebral malaria. Clin Infect Dis 21:300–9 [CrossRef] [PubMed] [Google Scholar]
  • Cordoliani YS, Sarrazin JL, Felten D, et al (1998) MR of cerebral malaria. AJNR Am J Neuroradiol 19:871–4 [PubMed] [Google Scholar]
  • WHO, Severe malaria (2014) Trop Med Int Health 19:7–131 [Google Scholar]
  • Jauréguiberry S, Kendjo É, Ndour A, et al (2012) Traitement par l'artésunate intraveineux en France. La lettre de l'infectiologue XXVII:244–51 [Google Scholar]
  • HCSP (2013) Place de l’artésunate injectable dans le traitement du paludisme grave de l’adulte et de l’enfant en France. [cited 2013; Available from: http://www.hcsp.fr/explore.cgi/telecharger/hcspr20130201_palugraveartesunate.pdf [Google Scholar]
  • Carme B, Demar M, Ajzenberg D, Dardé ML (2009) Severe acquired toxoplasmosis caused by wild cycle of Toxoplasma gondii, French Guiana. Emerg Infect Dis 15:656–8 [Google Scholar]
  • Béraud G, Pierre-François S, Foltzer A, et al (2009) Cotrimoxazole for treatment of cerebral toxoplasmosis: an observational cohort study during 1994–2006. Am J Trop Med Hyg 80:583–7 [PubMed] [Google Scholar]
  • Sonneville R, Schmidt M, Messika J, et al (2012) Neurologic outcomes and adjunctive steroids in HIV patients with severe cerebral toxoplasmosis. Neurology 79:1762–6 [CrossRef] [PubMed] [Google Scholar]
  • Garcia HH, Nash TE, Del Brutto OH (2014) Clinical symptoms, diagnosis, and treatment of neurocysticercosis. Lancet Neurol 13:1202–15 [CrossRef] [PubMed] [Google Scholar]
  • Coyle CM, Mahanty S, Zunt JR, et al (2012) Neurocysticercosis: neglected but not forgotten. PLoS Negl Trop Dis 6:e1500 [CrossRef] [PubMed] [Google Scholar]
  • Dournon N, Epelboin L, Brion MC, et al (2012) Seroconversion of neurocysticercosis occurring after anti-helminthic treatment. J Travel Med 19:383–6 [CrossRef] [PubMed] [Google Scholar]
  • Rodriguez S, Wilkins P, Dorny P (2012) Immunological and molecular diagnosis of cysticercosis. Pathog Glob Health 106:286–98 [CrossRef] [PubMed] [Google Scholar]
  • Del Brutto OH, Roos KL, Coffey CS, García HH (2006) Meta-analysis: cysticidal drugs for neurocysticercosis: albendazole and praziquantel. Ann Intern Med 145:43–51 [CrossRef] [PubMed] [Google Scholar]
  • Corona T, Lugo R, Medina R, Sotelo J (1996) Single-day praziquantel therapy for neurocysticercosis. N Engl J Med 334:125 [CrossRef] [Google Scholar]
  • Bustos JA, Pretell EJ, Llanos-Zavalaga F, et al (2006) Efficacy of a 3-day course of albendazole treatment in patients with a single neurocysticercosis cyst. Clin Neurol Neurosurg 108:193–4 [CrossRef] [PubMed] [Google Scholar]
  • Garcia HH, Gonzales I, Lescano AG, et al (2014) Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial. Lancet Infect Dis 14:687–95 [CrossRef] [PubMed] [Google Scholar]
  • Vazquez ML, Jung H, Sotelo J (1987) Plasma levels of praziquantel decrease when dexamethasone is given simultaneously. Neurology 37:1561–2 [CrossRef] [PubMed] [Google Scholar]
  • Finsterer J, Auer H (2007) Neurotoxocarosis. Rev Inst Med Trop Sao Paulo 49:279–87 [CrossRef] [PubMed] [Google Scholar]
  • Magnaval JF (1995) Comparative efficacy of diethylcarbamazine and mebendazole for the treatment of human toxocariasis. Parasitology 110:529–33 [CrossRef] [PubMed] [Google Scholar]
  • Gautret P, Clerinx J, Caumes E, et al (2009) Imported human African trypanosomiasis in Europe, 2005–2009. Euro Surveill 14:pii:19327 [Google Scholar]
  • Simarro PP, Franco JR, Cecchi G, et al (2012) Human African trypanosomiasis in non-endemic countries (2000–2010). J Travel Med 19:44–53 [CrossRef] [PubMed] [Google Scholar]
  • Jelinek T, Bisoffi Z, Bonazzi L, et al (2002) Cluster of African trypanosomiasis in travelers to Tanzanian national parks. Emerg Infect Dis 8:634–5 [CrossRef] [PubMed] [Google Scholar]
  • Rocha G, Martins A, Gama G, et al (2004) Possible cases of sexual and congenital transmission of sleeping sickness. Lancet 363:247 [CrossRef] [Google Scholar]
  • Docampo R, Moreno SN (2003) Current chemotherapy of human African trypanosomiasis. Parasitol Res 90:S10–S3 [PubMed] [Google Scholar]
  • Eperon G, Balasegaram M, Potet J, et al (2014) Treatment options for second-stage gambiense human African trypanosomiasis. Expert Rev Anti Infect Ther 12:1407–17 [CrossRef] [PubMed] [Google Scholar]
  • Moreira VL, Giese EG, Melo FT, et al (2013) Endemic angiostrongyliasis in the Brazilian Amazon: natural parasitism of Angiostrongylus cantonensis in Rattus rattus and Rattus norvegicus, and sympatric giant African land snails, Achatina fulica. Acta Trop 125:90–7 [CrossRef] [PubMed] [Google Scholar]
  • Eamsobhana P (2014) Eosinophilic meningitis caused by Angiostrongylus cantonensis — a neglected disease with escalating importance. Trop Biomed 31:569–78 [Google Scholar]
  • Sawanyawisuth K (2008) Treatment of angiostrongyliasis. Trans R Soc Trop Med Hyg 102:990–6 [CrossRef] [PubMed] [Google Scholar]
  • Thanaviratananich S, Ngamjarus C (2015) Corticosteroids for parasitic eosinophilic meningitis. Cochrane Database Syst Rev 2:CD009088 [PubMed] [Google Scholar]
  • Chotmongkol VK, Sawanyawisuth K, Thavornpitak Y (2000) Corticosteroid treatment of eosinophilic meningitis. Clin Infect Dis 31:660–2 [CrossRef] [PubMed] [Google Scholar]
  • Jauréguiberry S (2005) Manifestations neurologiques au cours des helminthiases invasives : à propos de 3 cas de neurobilharziose. In: Thèse d'exercice. Faculté de médecine, Rennes-I, p 63 [Google Scholar]
  • Granier H, Potard M, Diraison P, et al (2003) Acute encephalitis concurrent with primary infection by Schistosoma mansoni. Med Trop (Mars) 63:60–3 [PubMed] [Google Scholar]
  • Jaureguiberry S, Paris L, Caumes E (2010) Acute schistosomiasis, a diagnostic and therapeutic challenge. Clin Microbiol Infect 16:225–31 [CrossRef] [PubMed] [Google Scholar]
  • Kane C, Most H (1948) Schistosomiasis of the central nervous system. Arch Neurol Psychiatr 59:141–83 [CrossRef] [Google Scholar]
  • Jaureguiberry S, Caumes E (2008) Neurological involvement during Katayama syndrome. Lancet Infect Dis 8:9–10 [CrossRef] [PubMed] [Google Scholar]
  • Grandière-Pérez L, Ansart S, Paris L et al (2006) Efficacy of praziquantel during the incubation and invasive phase of Schistosoma haematobium schistosomiasis in 18 travelers. Am J Trop Med Hyg 74:814–8 [PubMed] [Google Scholar]
  • Keiser PB, Nutman TB (2004) Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 17:208–17 [CrossRef] [PubMed] [Google Scholar]
  • Fardet L, Généreau T, Poirot JL, et al (2007) Severe strongyloidiasis in corticosteroid-treated patients: case series and literature review. J Infect 54:18–27 [CrossRef] [PubMed] [Google Scholar]
  • Caumes E, Keystone JS (2011) Acute strongyloidiasis: a rarity. Chronic strongyloidiasis: a time bomb! J Travel Med 18:71–2 [CrossRef] [PubMed] [Google Scholar]
  • Geri G, Rabbat A, Mayaux J, et al (2015) Strongyloides stercoralis hyperinfection syndrome: a case series and a review of the literature. Infection 43:691–8 [CrossRef] [PubMed] [Google Scholar]
  • Leung V, Al-Rawahi GN, Grant J, et al (2008) Case report: failure of subcutaneous ivermectin in treating Strongyloides hyperinfection. Am J Trop Med Hyg 79:853–5 [PubMed] [Google Scholar]
  • Marty FM, Lowry CM, Rodriguez M, et al (2005) Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin. Clin Infect Dis 41:e5–e8 [CrossRef] [PubMed] [Google Scholar]
  • Pacanowski J, Santos MD, Roux A, et al (2005) Subcutaneous ivermectin as a safe salvage therapy in Strongyloides stercoralis hyperinfection syndrome: a case report. Am J Trop Med Hyg 73:122–4 [PubMed] [Google Scholar]
  • Buonfrate D, Requena-Mendez A, Angheben A, et al (2013) Severe strongyloidiasis: a systematic review of case reports. BMC Infect Dis 13:78 [CrossRef] [PubMed] [Google Scholar]
  • Herman JS, Wall EC, van-Tulleken C, et al (2009) Gnathostomiasis acquired by British tourists in Botswana. Emerg Infect Dis 15:594–7 [CrossRef] [PubMed] [Google Scholar]
  • Moore DA, McCroddan J, Dekumyoy P, Chiodini PL (2003) Gnathostomiasis: an emerging imported disease. Emerg Infect Dis 9:647–50 [Google Scholar]
  • Clement-Rigolet MC, Danis M, Caumes E (2004) Gnathostomosis, an exotic disease increasingly imported into Western countries. Presse Med 33:1527–32 [CrossRef] [PubMed] [Google Scholar]
  • Katchanov J, Sawanyawisuth K, Chotmongkoi V, Nawa Y (2011) Neurognathostomiasis, a neglected parasitosis of the central nervous system. Emerg Infect Dis 17:1174–80 [Google Scholar]
  • Boongird P, Phuapradit P, Siridej N, et al (1977) Neurological manifestations of gnathostomiasis. J Neurol Sci 31:279–91 [Google Scholar]
  • Chandenier J, Husson J, Canaple S, et al (2001) Medullary gnathostomiasis in a white patient: use of immunodiagnosis and magnetic resonance imaging. Clin Infect Dis 32:E154–E7 [CrossRef] [Google Scholar]
  • Laummaunwai P, Sawanyawisuth K, Intapan PM, et al (2007) Evaluation of human IgG class and subclass antibodies to a 24 kDa antigenic component of Gnathostoma spinigerum for the serodiagnosis of gnathostomiasis. Parasitol Res 101:703–8 [Google Scholar]
  • Sawanyawisuth K, Tiamkao S, Kanpittaya J, et al (2004) MR imaging findings in cerebrospinal gnathostomiasis. AJNR Am J Neuroradiol 25:446–9 [PubMed] [Google Scholar]
  • Nontasut P, Claesson BA, Dekumyoy P, et al (2005) Double-dose ivermectin vs albendazole for the treatment of gnathostomiasis. Southeast Asian J Trop Med Public Health 36:650–2 [PubMed] [Google Scholar]
  • Strady C, Dekumyoy P, Clement-Rigolet M, et al (2009) Long-term follow-up of imported gnathostomiasis shows frequent treatment failure. Am J Trop Med Hyg 80:33–5 [PubMed] [Google Scholar]
  • Grace ES, Asbill S, Virga K (2015) Naegleria fowleri: pathogenesis, diagnosis, and treatment options. Antimicrob Agents Chemother 59:6677–81 [CrossRef] [PubMed] [Google Scholar]
  • Visvesvara GS, Moura H, Schuster FL (2007) Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea. FEMS Immunol Med Microbiol 50:1–26 [CrossRef] [PubMed] [Google Scholar]
  • Capewell LG, Harris AM, Yoder JS, et al (2015) Diagnosis, clinical course, and treatment of primary amoebic meningoencephalitis in the United States, 1937–2013. J Pediatric Infect Dis Soc 4:e68–e75 [CrossRef] [PubMed] [Google Scholar]
  • Bertrand I, Callot J, Terrasse J, et al (1956) A new case of cerebral coenurosis. Presse Med 64:333–5 [Google Scholar]
  • Lescano AG, Zunt J (2013) Other cestodes: sparganosis, coenurosis and Taenia crassiceps cysticercosis. Handb Clin Neurol 114:335–45 [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.